Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 536
5
Diseases
3
Unique genes
0.345
Avg. similarity score
Benign familial pemphigus
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Benign familial pemphigus
Alport syndrome 2, autosomal recessive
Diffuse mesangial sclerosis
Hematuria, benign familial, 1
Hailey-hailey disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Benign familial pemphigus | 4 | 4 | 2 |
| Alport syndrome 2, autosomal recessive | 3 | 3 | 1 |
| Diffuse mesangial sclerosis | 3 | 3 | 2 |
| Hematuria, benign familial, 1 | 3 | 3 | 1 |
| Hailey-hailey disease | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL4A4 | 4 / 5 | Alport syndrome 2, autosomal recessive, Benign familial pemphigus, Diffuse mesangial sclerosis, Hematuria, benign familial, 1 |
| ATP2C1 | 2 / 5 | Benign familial pemphigus, Hailey-hailey disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Laminin interactions | Reactome | 2 / 28 | 286× | 1.57e-5 | 4.26e-4 ✓ sig. |
| ECM-receptor interaction | KEGG | 2 / 89 | 90.0× | 1.62e-4 | 2.78e-3 ✓ sig. |
| Small cell lung cancer | KEGG | 2 / 93 | 86.1× | 1.77e-4 | 2.98e-3 ✓ sig. |
| Amoebiasis | KEGG | 2 / 103 | 77.7× | 2.17e-4 | 3.50e-3 ✓ sig. |
| Focal adhesion | KEGG | 2 / 203 | 39.4× | 8.43e-4 | 9.95e-3 ✓ sig. |
| Human papillomavirus infection | KEGG | 2 / 333 | 24.0× | 2.26e-3 | 2.08e-2 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 2 / 361 | 22.2× | 2.65e-3 | 2.34e-2 ✓ sig. |
| Extracellular matrix organization | Reactome | 1 / 15 | 267× | 3.74e-3 | 2.98e-2 ✓ sig. |
| Anchoring fibril formation | Reactome | 1 / 15 | 267× | 3.74e-3 | 2.98e-2 ✓ sig. |
| Crosslinking of collagen fibrils | Reactome | 1 / 18 | 222× | 4.49e-3 | 3.39e-2 ✓ sig. |
| NCAM1 interactions | Reactome | 1 / 21 | 191× | 5.24e-3 | 3.76e-2 ✓ sig. |
| Pathways in cancer | KEGG | 2 / 533 | 15.0× | 5.72e-3 | 4.00e-2 ✓ sig. |
| Non-integrin membrane-ECM interactions | Reactome | 1 / 24 | 167× | 5.98e-3 | 4.10e-2 ✓ sig. |
| MET activates PTK2 signaling | Reactome | 1 / 30 | 133× | 7.48e-3 | 4.73e-2 ✓ sig. |
| Signaling by PDGF | Reactome | 1 / 33 | 121× | 8.22e-3 | 5.04e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| metanephric glomerular basement membrane development | GO:0072274 | 1 / 1 | 6,229× | 1.61e-4 | 4.34e-3 ✓ sig. |
| Golgi calcium ion homeostasis | GO:0032468 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| Golgi calcium ion transport | GO:0032472 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| trans-Golgi network membrane organization | GO:0098629 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| metanephric podocyte development | GO:0072249 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| axon extension involved in regeneration | GO:0048677 | 1 / 3 | 2,076× | 4.82e-4 | 9.24e-3 ✓ sig. |
| intracellular manganese ion homeostasis | GO:0030026 | 1 / 5 | 1,246× | 8.03e-4 | 1.28e-2 ✓ sig. |
| positive regulation of Golgi to plasma membrane protein transport | GO:0042998 | 1 / 6 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| regulation of basement membrane organization | GO:0110011 | 1 / 6 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| manganese ion transport | GO:0006828 | 1 / 9 | 692× | 1.44e-3 | 1.79e-2 ✓ sig. |
| manganese ion transmembrane transport | GO:0071421 | 1 / 9 | 692× | 1.44e-3 | 1.79e-2 ✓ sig. |
| glomerular basement membrane development | GO:0032836 | 1 / 10 | 623× | 1.60e-3 | 1.88e-2 ✓ sig. |
| positive regulation of integrin-mediated signaling pathway | GO:2001046 | 1 / 13 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |
| astrocyte development | GO:0014002 | 1 / 15 | 415× | 2.41e-3 | 2.32e-2 ✓ sig. |
| positive regulation of muscle cell differentiation | GO:0051149 | 1 / 16 | 389× | 2.57e-3 | 2.40e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Alport syndrome 2, autosomal recessive | Hematuria, benign familial, 1 | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Alport syndrome 2, autosomal recessive | Diffuse mesangial sclerosis | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Alport syndrome 2, autosomal recessive | Benign familial pemphigus | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Benign familial pemphigus | Hematuria, benign familial, 1 | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Benign familial pemphigus | Hailey-hailey disease | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Diffuse mesangial sclerosis | Hematuria, benign familial, 1 | 0.333 | 1 | 1.29e-4 | 3.27e-4 ✓ sig. |
| Benign familial pemphigus | Diffuse mesangial sclerosis | 0.250 | 1 | 2.58e-4 | 5.38e-4 ✓ sig. |